Hematology NewsBlinatumomab triggers complete MRD response in ALLApril 12, 2018ALLLeukemia, Myelodysplasia, TransplantationImmuno-oncology
Oncology PracticeSurgery after immunotherapy effective in advanced melanomaApril 10, 2018MelanomaImmuno-oncology
Oncology PracticeCheckpoint inhibition less toxic than antiangiogenic therapy in NSCLCMarch 30, 2018Lung CancerImmuno-oncology
Oncology PracticeNivolumab helps some with advanced NSCLC reach 5-year markMarch 28, 2018Lung CancerImmuno-oncology
Oncology PracticeHDAC inhibition may boost immune therapy efficacy in breast cancerMarch 27, 2018Immuno-oncologyBreast Cancer
Oncology PracticeChemotherapy, metabolic pathway may affect CAR T-cell potentialMarch 22, 2018Immuno-oncologyALLLeukemia, Myelodysplasia, TransplantationSarcoma & GIST
Oncology PracticeCancer groups offer guidance on immune-related adverse eventsMarch 9, 2018Immuno-oncologyPatient & Survivor CareImmunotherapyCellular Therapy
Oncology PracticeDNA repair gene mutations predict response to anti–PD-1/PD-L1 in urothelial cancerMarch 7, 2018Immuno-oncologyGenitourinary Cancer
Oncology PracticeAvelumab safety compares with other checkpoint inhibitorsMarch 5, 2018Immuno-oncologyGynecologic CancerGenitourinary Cancer
Oncology PracticeImmunotherapy regimen influences inflammatory arthritis presentationMarch 5, 2018Patient & Survivor CareImmuno-oncologyAggressive LymphomasRenal Cell CarcinomaMelanoma
Oncology PracticeObjective response rate correlates poorly with overall survival in checkpoint-inhibitor trialsFebruary 22, 2018Immuno-oncology
Oncology PracticeThe T-cell repertoire in NSCLC: Therapeutic implicationsFebruary 14, 2018Lung CancerImmuno-oncology
Oncology PracticeStudy explores biological implications of MHC-II expression in tumor cellsFebruary 13, 2018Immuno-oncology
Oncology PracticeStudy: Test for PD-L1 amplification in solid tumorsFebruary 7, 2018Nonmelanoma Skin CancerImmuno-oncologyCNS/Brain Cancer
Oncology PracticeNew model predicts survival in atezolizumab-treated advanced urothelial carcinomaFebruary 7, 2018Immuno-oncologyGenitourinary Cancer
